Literature DB >> 16203997

Marek's disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: a converging transforming pathway for avian oncoviruses.

Alon M Levy1, Oren Gilad, Liang Xia, Yoshihiro Izumiya, Jonathan Choi, Anya Tsalenko, Zohar Yakhini, Richard Witter, Lucy Lee, Carol J Cardona, Hsing-Jien Kung.   

Abstract

Marek's disease virus (MDV) is a highly pathogenic and oncogenic herpesvirus of chickens. MDV encodes a basic leucine zipper (bZIP) protein, Meq (MDV EcoQ). The bZIP domain of Meq shares homology with Jun/Fos, whereas the transactivation/repressor domain is entirely different. Increasing evidence suggests that Meq is the oncoprotein of MDV. Direct evidence that Meq transforms chicken cells and the underlying mechanism, however, remain completely unknown. Taking advantage of the DF-1 chicken embryo fibroblast transformation system, a well established model for studying avian sarcoma and leukemia oncogenes, we probed the transformation properties and pathways of Meq. We found that Meq transforms DF-1, with a cell morphology akin to v-Jun and v-Ski transformed cells, and protects DF-1 from apoptosis, and the transformed cells are tumorigenic in chorioallantoic membrane assay. Significantly, using microarray and RT-PCR analyses, we have identified up-regulated genes such as JTAP-1, JAC, and HB-EGF, which belong to the v-Jun transforming pathway. In addition, c-Jun was found to form stable dimers with Meq and colocalize with it in the transformed cells. RNA interference to Meq and c-Jun down-modulated the expression of these genes and reduced the growth of the transformed DF-1, suggesting that Meq transforms chicken cells by pirating the Jun pathway. These data suggest that avian herpesvirus and retrovirus oncogenes use a similar strategy in transformation and oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16203997      PMCID: PMC1253582          DOI: 10.1073/pnas.0506849102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus.

Authors:  L F Lee; P Wu; D Sui; D Ren; J Kamil; H J Kung; R L Witter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 2.  Meq: an MDV-specific bZIP transactivator with transforming properties.

Authors:  H J Kung; L Xia; P Brunovskis; D Li; J L Liu; L F Lee
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

3.  Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius.

Authors:  P E Neiman; A Ruddell; C Jasoni; G Loring; S J Thomas; K A Brandvold; J Burnside; J Delrow
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

4.  Role for a Drosophila Myb-containing protein complex in site-specific DNA replication.

Authors:  Eileen L Beall; J Robert Manak; Sharleen Zhou; Maren Bell; Joseph S Lipsick; Michael R Botchan
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

5.  The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses.

Authors:  M Himly; D N Foster; I Bottoli; J S Iacovoni; P K Vogt
Journal:  Virology       Date:  1998-09-01       Impact factor: 3.616

Review 6.  Jun, the oncoprotein.

Authors:  P K Vogt
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

7.  c-Jun associates with the oncoprotein Ski and suppresses Smad2 transcriptional activity.

Authors:  Marcia Pessah; Jacqueline Marais; Celine Prunier; Nathalie Ferrand; Francois Lallemand; Alain Mauviel; Azeddine Atfi
Journal:  J Biol Chem       Date:  2002-05-28       Impact factor: 5.157

8.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

9.  JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis.

Authors:  M Hartl; F Reiter; A G Bader; M Castellazzi; K Bister
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

10.  TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).

Authors:  A G Bader; M L Schneider; K Bister; M Hartl
Journal:  Oncogene       Date:  2001-11-08       Impact factor: 9.867

View more
  31 in total

1.  Marek's disease virus encodes MicroRNAs that map to meq and the latency-associated transcript.

Authors:  Joan Burnside; Erin Bernberg; Amy Anderson; Cheng Lu; Blake C Meyers; Pamela J Green; Neeta Jain; Grace Isaacs; Robin W Morgan
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  The oncogenic microRNA OncomiR-21 overexpressed during Marek's disease lymphomagenesis is transactivated by the viral oncoprotein Meq.

Authors:  Grégoire Stik; Ginette Dambrine; Sébastien Pfeffer; Denis Rasschaert
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

3.  Integrated analyses of genome-wide DNA occupancy and expression profiling identify key genes and pathways involved in cellular transformation by a Marek's disease virus oncoprotein, Meq.

Authors:  Sugalesini Subramaniam; John Johnston; Likit Preeyanon; C Titus Brown; Hsing-Jien Kung; Hans H Cheng
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

4.  Marek's disease virus type 1 microRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting Smad2 of the transforming growth factor beta signal pathway.

Authors:  Shun Xu; Chunyi Xue; Jianping Li; Yingzuo Bi; Yongchang Cao
Journal:  J Virol       Date:  2010-10-20       Impact factor: 5.103

5.  Analysis of transcriptional activities of the Meq proteins present in highly virulent Marek's disease virus strains, RB1B and Md5.

Authors:  Shiro Murata; Tsukasa Okada; Rika Kano; Yuko Hayashi; Tomoyuki Hashiguchi; Misao Onuma; Satoru Konnai; Kazuhiko Ohashi
Journal:  Virus Genes       Date:  2011-04-19       Impact factor: 2.332

6.  Viral control of vTR expression is critical for efficient formation and dissemination of lymphoma induced by Marek's disease virus (MDV).

Authors:  Najat Chbab; Annemarie Egerer; Inês Veiga; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  Vet Res       Date:  2010-04-29       Impact factor: 3.683

7.  The Meq oncoprotein of Marek's disease virus interacts with p53 and inhibits its transcriptional and apoptotic activities.

Authors:  Xufang Deng; Xiangdong Li; Yang Shen; Yafeng Qiu; Zixue Shi; Donghua Shao; Yamei Jin; Hongjun Chen; Chan Ding; Li Li; Puyan Chen; Zhiyong Ma
Journal:  Virol J       Date:  2010-11-26       Impact factor: 4.099

8.  Homodimerization of the Meq viral oncoprotein is necessary for induction of T-cell lymphoma by Marek's disease virus.

Authors:  Andrew C Brown; Lorraine P Smith; Lydia Kgosana; Susan J Baigent; Venugopal Nair; Martin J Allday
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

9.  Sequence conservation and differential expression of Marek's disease virus microRNAs.

Authors:  Robin Morgan; Amy Anderson; Erin Bernberg; Sachin Kamboj; Emily Huang; Grace Lagasse; Grace Isaacs; Mark Parcells; Blake C Meyers; Pamela J Green; Joan Burnside
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

10.  Homodimerization of Marek's disease virus-encoded Meq protein is not sufficient for transformation of lymphocytes in chickens.

Authors:  Paulette F Suchodolski; Yoshihiro Izumiya; Blanca Lupiani; Dharani K Ajithdoss; Oren Gilad; Lucy F Lee; Hsing-Jien Kung; Sanjay M Reddy
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.